- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 6 residues within 4Å:- Chain A: N.523, A.526, R.528, T.547, M.549, E.550
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:N.523, A:A.526, A:T.547
MG.16: 6 residues within 4Å:- Chain B: N.523, A.526, R.528, T.547, M.549, E.550
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:N.523, B:A.526, B:T.547
MG.25: 5 residues within 4Å:- Chain C: N.523, L.524, G.546, T.547, M.549
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:N.523, C:T.547, C:M.549
MG.34: 5 residues within 4Å:- Chain D: N.523, L.524, G.546, T.547, M.549
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:N.523, D:T.547, D:M.549
- 16 x 6PL: (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE(Non-covalent)(Covalent)
6PL.4: 7 residues within 4Å:- Chain A: D.276, L.278, D.279, D.281, L.313, F.320
- Ligands: 6PL.38
Ligand excluded by PLIP6PL.5: 12 residues within 4Å:- Chain A: I.138, L.229, V.232, V.241, L.242, K.243, T.244, S.247, L.250, S.255, I.258, L.262
Ligand excluded by PLIP6PL.6: 7 residues within 4Å:- Chain A: L.227, R.249, I.267, I.328, S.331
- Chain D: T.342
- Ligands: CLR.8
Ligand excluded by PLIP6PL.7: 10 residues within 4Å:- Chain A: W.261, S.287, W.289, T.290, Y.293
- Chain C: V.312, R.315, T.316, F.320
- Ligands: 6PL.26
Ligand excluded by PLIP6PL.17: 7 residues within 4Å:- Chain B: D.276, L.278, D.279, D.281, L.313, F.320
- Ligands: 6PL.29
Ligand excluded by PLIP6PL.18: 12 residues within 4Å:- Chain B: I.138, L.229, V.232, V.241, L.242, K.243, T.244, S.247, L.250, S.255, I.258, L.262
Ligand excluded by PLIP6PL.19: 7 residues within 4Å:- Chain B: L.227, R.249, I.267, I.328, S.331
- Chain C: T.342
- Ligands: CLR.21
Ligand excluded by PLIP6PL.20: 9 residues within 4Å:- Chain B: W.261, S.287, W.289, T.290, Y.293
- Chain D: V.312, T.316, F.320
- Ligands: 6PL.35
Ligand excluded by PLIP6PL.26: 10 residues within 4Å:- Chain C: D.276, L.278, D.279, D.281, N.282, V.312, L.313, T.316, F.320
- Ligands: 6PL.7
Ligand excluded by PLIP6PL.27: 8 residues within 4Å:- Chain C: L.229, V.241, L.242, K.243, T.244, S.247, L.250, I.258
Ligand excluded by PLIP6PL.28: 8 residues within 4Å:- Chain C: L.227, M.230, R.249, I.256, V.260, I.267, I.328
- Ligands: CLR.30
Ligand excluded by PLIP6PL.29: 10 residues within 4Å:- Chain B: V.312, V.319, F.320
- Chain C: W.261, S.287, W.289, T.290, V.292, Y.293
- Ligands: 6PL.17
Ligand excluded by PLIP6PL.35: 10 residues within 4Å:- Chain D: D.276, L.278, D.279, D.281, N.282, V.312, L.313, T.316, F.320
- Ligands: 6PL.20
Ligand excluded by PLIP6PL.36: 8 residues within 4Å:- Chain D: L.229, V.241, L.242, K.243, T.244, S.247, L.250, I.258
Ligand excluded by PLIP6PL.37: 8 residues within 4Å:- Chain D: L.227, M.230, R.249, I.256, V.260, I.267, I.328
- Ligands: CLR.39
Ligand excluded by PLIP6PL.38: 9 residues within 4Å:- Chain A: V.312, T.316
- Chain D: W.261, S.287, W.289, T.290, V.292, Y.293
- Ligands: 6PL.4
Ligand excluded by PLIP- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.8: 7 residues within 4Å:- Chain A: L.53, F.199, F.203, L.271, S.274, F.280
- Ligands: 6PL.6
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.53, A:L.53, A:F.199, A:F.203, A:L.271
- Hydrogen bonds: A:S.274
CLR.21: 7 residues within 4Å:- Chain B: L.53, F.199, F.203, L.271, S.274, F.280
- Ligands: 6PL.19
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:L.53, B:L.53, B:F.199, B:F.203, B:L.271
- Hydrogen bonds: B:S.274
CLR.30: 7 residues within 4Å:- Chain C: L.53, I.57, F.60, F.203, S.274, F.280
- Ligands: 6PL.28
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:L.53, C:I.57, C:F.60, C:F.203
- Hydrogen bonds: C:S.274, C:S.274
CLR.39: 7 residues within 4Å:- Chain D: L.53, I.57, F.60, F.203, S.274, F.280
- Ligands: 6PL.37
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:L.53, D:I.57, D:F.60, D:F.203
- Hydrogen bonds: D:S.274, D:S.274
- 6 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
K.9: 9 residues within 4Å:- Chain A: G.303, Y.304
- Chain B: G.303, Y.304
- Chain C: G.303, Y.304
- Chain D: G.303, Y.304
- Ligands: K.10
4 PLIP interactions:1 interactions with chain A, 1 interactions with chain B, 1 interactions with chain D, 1 interactions with chain C- Metal complexes: A:G.303, B:G.303, D:G.303, C:G.303
K.10: 10 residues within 4Å:- Chain A: V.302, G.303
- Chain B: V.302, G.303
- Chain C: V.302, G.303
- Chain D: V.302, G.303
- Ligands: K.9, K.11
5 PLIP interactions:1 interactions with chain A, 2 interactions with chain D, 1 interactions with chain C, 1 interactions with chain B- Metal complexes: A:G.303, D:V.302, D:G.303, C:V.302, B:V.302
K.11: 10 residues within 4Å:- Chain A: T.301, V.302
- Chain B: T.301, V.302
- Chain C: T.301, V.302
- Chain D: T.301, V.302
- Ligands: K.10, K.12
5 PLIP interactions:2 interactions with chain A, 1 interactions with chain C, 1 interactions with chain D, 1 interactions with chain B- Metal complexes: A:T.301, A:V.302, C:V.302, D:T.301, B:T.301
K.12: 6 residues within 4Å:- Chain A: T.301
- Chain B: T.301
- Chain C: T.301
- Chain D: T.301
- Ligands: K.11, K.13
4 PLIP interactions:1 interactions with chain C, 2 interactions with chain B, 1 interactions with chain A- Metal complexes: C:T.301, B:T.301, B:T.301, A:T.301
K.13: 4 residues within 4Å:- Chain A: T.301
- Chain C: T.301
- Ligands: K.12, 8I2.22
No protein-ligand interaction detected (PLIP)K.31: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)- 1 x 8I2: (3~{S},6~{R},9~{S},12~{R},15~{S},18~{R},21~{S},24~{R})-4,6,10,16,18,22-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-12,24-bis[(4-morpholin-4-ylphenyl)methyl]-1,7,13,19-tetraoxa-4,10,16,22-tetrazacyclotetracosane-2,5,8,11,14,17,20,23-octone(Non-covalent)
8I2.22: 33 residues within 4Å:- Chain A: F.257, I.296, M.299, T.301, L.326, A.327, F.329, A.330, I.333
- Chain B: F.257, I.296, M.299, T.301, L.326, A.327, F.329, A.330, I.333
- Chain C: S.300, T.301, L.322, L.323, L.326, F.329, A.330, P.334
- Chain D: T.301, L.322, L.323, L.326, F.329, P.334
- Ligands: K.13
13 PLIP interactions:3 interactions with chain B, 4 interactions with chain C, 3 interactions with chain D, 3 interactions with chain A- Hydrophobic interactions: B:L.326, B:A.330, B:I.333, C:L.326, C:F.329, C:A.330, C:P.334, D:T.301, D:F.329, D:P.334, A:L.326, A:A.330, A:I.333
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Raisch, T. et al., Small molecule modulation of the Drosophila Slo channel elucidated by cryo-EM. Nat Commun (2021)
- Release Date
- 2021-12-15
- Peptides
- Isoform J of Calcium-activated potassium channel slowpoke: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 16 x 6PL: (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE(Non-covalent)(Covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 6 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
- 1 x 8I2: (3~{S},6~{R},9~{S},12~{R},15~{S},18~{R},21~{S},24~{R})-4,6,10,16,18,22-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-12,24-bis[(4-morpholin-4-ylphenyl)methyl]-1,7,13,19-tetraoxa-4,10,16,22-tetrazacyclotetracosane-2,5,8,11,14,17,20,23-octone(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Raisch, T. et al., Small molecule modulation of the Drosophila Slo channel elucidated by cryo-EM. Nat Commun (2021)
- Release Date
- 2021-12-15
- Peptides
- Isoform J of Calcium-activated potassium channel slowpoke: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.